by Kim North Shine, University of Michigan Credit: Unsplash/CC0 Public DomainFirst boosters, second boosters, monovalent, bivalent. Just like the SARS-CoV-2 virus strain, the vaccines to combat the virus are always changing—and perhaps confusing. With the goal of better understanding the variety of vaccines and the methods used globally to study vaccines’ effectiveness, a group of University...
Tag: <span>severe disease</span>
New COVID variants better infect lungs, could cause more severe disease
By Rich Haridy Research indicates newer COVID variants stemming from BA.2.86 can infect the lungs more effectively than any variant since Delta Depositphotos A newly published study from researchers at Ohio State University has found the recently emerged BA.2.86 variant of SARS-CoV-2 has a greater propensity for infecting certain lung cells than any prior Omicron variant....
Experimental COVID-19 vaccine offers long-term protection against severe disease
by University of North Carolina Health Care Experimental Design. Two groups of 2-month old rhesus macaques (RMs) were immunized intramuscularly at weeks (wks) 0 and 4 with stabilized prefusion SARS-CoV-2 S-2P spike (S) protein of the Washington (SARS-CoV-2/human/USA/WA-CDC-02982586-001/2020) strain encoded by mRNA encapsulated in lipid nanoparticles (mRNA-LNP; n = 8) or purified S protein mixed with 3...
COVID-19 vaccination protects adults on dialysis against infection and severe disease
by American Society of Nephrology Multiple studies have shown that individuals with kidney failure who are undergoing dialysis mount weaker antibody responses after COVID-19 vaccination than people in the general population, but new research indicates that these individuals’ immune responses are still capable of protecting against SARS-CoV-2 infection and severe COVID-19. The findings are published...